Seppo Meri

Seppo Meri is a Research Director at the Department of Bacteriology and Immunology, University of Helsinki, and a supervisor in the Doctoral Programmes in Biomedicine, Clinical Research, and Population Health. His research focuses on the complement system, immunology, nephrology, and infectious diseases, with a particular emphasis on diseases like C3 glomerulopathy, malaria, and rheumatoid arthritis. He has led major projects funded by the Sigrid Jusélius Foundation, Finnish Academy, and Magnus Ehrnrooth Foundation, including studies on complement dysregulation, vaccine development, and cancer progression.

• Projects: Juselius 2025-2028 (€73,000), Malaria Mechanisms (2025-2026), Magnus Ehrnrooth 2024-2026 (€20,000)

His work explores the intersection of inflammation, complement activation, and disease mechanisms in conditions like Alzheimer’s, atherosclerosis, and post-transplant complications. Key trends include complement-targeted therapies and microbial immune evasion strategies.

Scientific awards include the ECN Gold Medal (2019), Labquality Prize (2014), and membership in The Finnish Academy of Sciences (2009). He has supervised students such as Lokki, A.I. (2023-2024) and Kant, R. (2023-ongoing), while contributing to malaria control trials in Tanzania and complement research in rare diseases.